Publication | Closed Access

Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia

Hematological MalignancyOncologyElderly PatientsMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaHematologyMalignant Blood DisorderLow-dose CytarabinePharmacotherapyPharmacologyMyeloid Neoplasia